DJ Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ advanced 1.01% to $54.98 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.24% to 6,144.15 and the Dow Jones Industrial Average rising 0.16% to 44,627.59.
This was the stock's second consecutive day of gains.
Bristol Myers Squibb Co. closed 10.02% below its 52-week high of $61.10, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.87% to $157.89, Pfizer Inc. $(PFE)$ rose 1.29% to $25.89, and Abbott Laboratories $(ABT)$ rose 1.50% to $132.13.
Trading volume (10.6 M) remained 540,416 below its 50-day average volume of 11.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 19, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 19, 2025 16:39 ET (21:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。